<Summary id="CDR0000258027" LegacyPDQID="2614" ReplacementFor="CDR0000062803"><SummaryMetaData><SummaryType>Screening</SummaryType><SummaryAudience>Patients</SummaryAudience><SummaryLanguage>English</SummaryLanguage><SummaryDescription>Ovarian, fallopian tube, or primary peritoneal cancers screening has not been shown to reduce the chance of dying from these cancers. Not all screening tests are helpful, and many have risks. Learn more the potential benefits and harms of screening in this expert-reviewed summary.</SummaryDescription><SummaryURL xref="https://www.cancer.gov/types/ovarian/patient/ovarian-screening-pdq">Ovarian, Fallopian Tube, and Primary Peritoneal Cancer (PDQ®): Screening</SummaryURL><SummaryToggleURL xref="https://www.cancer.gov/types/ovarian/hp/ovarian-screening-pdq">Ovarian, Fallopian Tube, and Primary Peritoneal Cancer (PDQ®): Screening</SummaryToggleURL><SummaryEditorialBoard ref="CDR0000028536">PDQ Screening and Prevention Editorial Board</SummaryEditorialBoard><MainTopics><TermRef ref="CDR0000043701">ovarian epithelial cancer</TermRef></MainTopics><MainTopics><TermRef ref="CDR0000040968">fallopian tube cancer</TermRef></MainTopics><MainTopics><TermRef ref="CDR0000040969">primary peritoneal cavity cancer</TermRef></MainTopics><MainTopics><TermRef ref="CDR0000038613">disease screening</TermRef></MainTopics><SummaryAbstract><Para id="_85">This PDQ cancer information summary has current information about ovarian, fallopian tube, and primary peritoneal cancers screening. It is meant to inform and help patients, families, and caregivers. It does not give formal guidelines or recommendations for making decisions about health care.</Para><Para id="_86">Editorial Boards write the PDQ cancer information summaries and keep them up to date. These Boards are made up of experts in cancer treatment and other specialties related to cancer. The summaries are reviewed regularly and changes are made when there is new information. The date on each summary ("Date Last Modified") is the date of the most recent change. The information in this patient summary was taken from the health professional version, which is reviewed regularly and updated as needed, by the PDQ Screening and Prevention Editorial Board.</Para></SummaryAbstract><SummaryKeyWords><SummaryKeyWord>disease screening</SummaryKeyWord><SummaryKeyWord>fallopian tube cancer</SummaryKeyWord><SummaryKeyWord>ovarian epithelial cancer</SummaryKeyWord><SummaryKeyWord>primary peritoneal cavity cancer</SummaryKeyWord></SummaryKeyWords></SummaryMetaData><SummaryTitle>Ovarian, Fallopian Tube, and Primary Peritoneal Cancers Screening (PDQ®)–Patient Version</SummaryTitle><AltTitle TitleType="Browser">Ovarian, Fallopian Tube, &amp; Primary Peritoneal Cancers Screening</AltTitle><AltTitle TitleType="CancerTypeHomePage">Ovarian, Fallopian Tube, &amp; Primary Peritoneal Cancers Screening</AltTitle><SummarySection id="_1"><Title>What Is Screening?</Title><Para id="_2"><GlossaryTermRef href="CDR0000046171" dictionary="Cancer.gov" audience="Patient">Screening</GlossaryTermRef> is  looking for <GlossaryTermRef href="CDR0000045333" dictionary="Cancer.gov" audience="Patient">cancer</GlossaryTermRef> before a person has any <GlossaryTermRef href="CDR0000045022" dictionary="Cancer.gov" audience="Patient">symptoms</GlossaryTermRef>. This can help find
		cancer at an early <GlossaryTermRef href="CDR0000045885" dictionary="Cancer.gov" audience="Patient">stage</GlossaryTermRef>. When <GlossaryTermRef href="CDR0000044636" dictionary="Cancer.gov" audience="Patient">abnormal</GlossaryTermRef> <GlossaryTermRef href="CDR0000046683" dictionary="Cancer.gov" audience="Patient">tissue</GlossaryTermRef> or cancer is found early, it may
		be easier to treat. By the time symptoms  appear, cancer may have begun
		to  spread.</Para><Para id="_3"><GlossaryTermRef href="CDR0000044724" dictionary="Cancer.gov" audience="Patient">Scientists</GlossaryTermRef>  are trying to better understand which
		people are more likely to get certain types of cancer. They also study the things
		we do and the things around us to see if they cause  cancer. This
		information helps doctors recommend who should be screened for cancer, which
		screening tests should be used, and how often the tests should be done.</Para><Para id="_4">It is important to remember that your doctor does not necessarily
		think you have cancer if he or she suggests a  <GlossaryTermRef href="CDR0000810044" dictionary="Cancer.gov" audience="Patient">screening test</GlossaryTermRef>. Screening
		tests are given when you  have no cancer symptoms.</Para><Para id="_53">If a screening test result is abnormal, you may need to have more tests done to find out if you have cancer. These are called <GlossaryTermRef href="CDR0000689569" dictionary="Cancer.gov" audience="Patient">diagnostic tests</GlossaryTermRef>.</Para></SummarySection><SummarySection id="_5"><Title>General Information About Ovarian, Fallopian Tube, and Primary Peritoneal Cancers</Title><SummarySection id="_6"><SectMetaData><SectionType>Cancer description</SectionType><SectionType>Organ description</SectionType></SectMetaData><KeyPoint id="_7">Ovarian, fallopian tube, and primary peritoneal cancers are diseases in which malignant (cancer) cells
		  form in the ovaries, fallopian tubes, or peritoneum.</KeyPoint><Para id="_8">The <GlossaryTermRef href="CDR0000046687" dictionary="Cancer.gov" audience="Patient">ovaries</GlossaryTermRef> are a pair
		  of organs in the female <GlossaryTermRef href="CDR0000046564" dictionary="Cancer.gov" audience="Patient">reproductive
		  system</GlossaryTermRef>. They are in the <GlossaryTermRef href="CDR0000046246" dictionary="Cancer.gov" audience="Patient">pelvis</GlossaryTermRef>, one on each side of the
		  uterus (the hollow, pear-shaped
		  organ where a <GlossaryTermRef href="CDR0000046400" dictionary="Cancer.gov" audience="Patient">fetus</GlossaryTermRef> grows). Each
		  ovary is about the size and shape of an almond. The ovaries make eggs and
		  female <GlossaryTermRef href="CDR0000045713" dictionary="Cancer.gov" audience="Patient">hormones</GlossaryTermRef> (<GlossaryTermRef href="CDR0000643008" dictionary="Cancer.gov" audience="Patient">chemicals</GlossaryTermRef> that
		  control the way certain cells or
		  organs work in the body).</Para><Para id="_83">The <GlossaryTermRef href="CDR0000045687" dictionary="Cancer.gov" audience="Patient">fallopian tubes</GlossaryTermRef> are a pair of long, slender tubes, one on each side of the uterus. Eggs pass from the ovaries, through the fallopian tubes, to the uterus. Cancer sometimes begins at the end of the fallopian tube near the ovary and spreads to the ovary.</Para><Para id="_84">The  <GlossaryTermRef href="CDR0000045829" dictionary="Cancer.gov" audience="Patient">peritoneum</GlossaryTermRef> is the tissue that lines the <GlossaryTermRef href="CDR0000046684" dictionary="Cancer.gov" audience="Patient">abdominal</GlossaryTermRef> wall and covers organs in the abdomen. <GlossaryTermRef href="CDR0000386215" dictionary="Cancer.gov" audience="Patient">Primary peritoneal cancer</GlossaryTermRef> is cancer that forms in the peritoneum and has not spread there from another part of the body. Cancer sometimes begins in the peritoneum and spreads to the ovary.</Para><Para id="_87"><GlossaryTermRef href="CDR0000046768" dictionary="Cancer.gov" audience="Patient">Ovarian epithelial cancer</GlossaryTermRef>, <GlossaryTermRef href="CDR0000755773" dictionary="Cancer.gov" audience="Patient">fallopian tube cancer</GlossaryTermRef>, and primary peritoneal cancer form in the same type of tissue. Studies of screening tests look at these cancers together.</Para><MediaLink ref="CDR0000609921" type="image/jpeg" alt="Anatomy of the female reproductive system; drawing shows the uterus, myometrium (muscular outer layer of the uterus), endometrium (inner lining of the uterus), ovaries, fallopian tubes, cervix, and vagina." language="en" placement="image-center" id="_79"><Caption language="en">Anatomy of the female reproductive system. The organs in the female reproductive system include the uterus, ovaries, fallopian tubes, cervix, and vagina. The uterus has a muscular outer layer called the myometrium and an inner lining called the endometrium. </Caption></MediaLink><Para id="_76">Other <GlossaryTermRef href="CDR0000044271" dictionary="Cancer.gov" audience="Patient">PDQ</GlossaryTermRef> summaries containing information related to <GlossaryTermRef href="CDR0000445074" dictionary="Cancer.gov" audience="Patient">ovarian</GlossaryTermRef>, fallopian tube, and primary peritoneal cancers include:</Para><ItemizedList id="_77" Style="bullet"><ListItem><SummaryRef href="CDR0000062822" url="/types/ovarian/patient/ovarian-prevention-pdq"> Ovarian, Fallopian Tube, and Primary Peritoneal Cancers Prevention</SummaryRef></ListItem><ListItem><SummaryRef href="CDR0000062855" url="/types/breast/hp/breast-ovarian-genetics-pdq">Genetics of Breast and Gynecologic Cancers</SummaryRef> (written for health professionals)</ListItem><ListItem><SummaryRef href="CDR0000062963" url="/types/ovarian/patient/ovarian-epithelial-treatment-pdq">Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancers Treatment</SummaryRef></ListItem></ItemizedList></SummarySection><SummarySection id="_9"><SectMetaData><SectionType>Incidence</SectionType></SectMetaData><KeyPoint id="_10">In the United States, ovarian cancer is the sixth-leading cause of death from cancer  in women.</KeyPoint><Para id="_11">Although ovarian cancer is rare, it is the sixth-leading cause of  death from cancer in women. It  is also the leading cause of death from cancer of the female reproductive system. The number of new cases of ovarian cancer have been decreasing slightly each year since at least the 1970s. There was also a slight decrease in the number of deaths from ovarian cancer each year from 2004 to 2022.</Para></SummarySection><SummarySection id="_56"><SectMetaData><SectionType>Risk factors</SectionType></SectMetaData><KeyPoint id="_57"> Different factors increase or decrease the risk of getting ovarian, fallopian tube, and primary peritoneal cancers.</KeyPoint><Para id="_15">Anything that increases your chance of getting a disease
		  is called a <GlossaryTermRef href="CDR0000045873" dictionary="Cancer.gov" audience="Patient">risk factor</GlossaryTermRef>. Anything that decreases your chance of getting a disease is called a <GlossaryTermRef href="CDR0000439422" dictionary="Cancer.gov" audience="Patient">protective factor</GlossaryTermRef>. Talk to your doctor if you think you may be at risk for ovarian cancer.</Para><Para id="_82">To learn more, visit <SummaryRef href="CDR0000062822" url="/types/ovarian/patient/ovarian-prevention-pdq">Ovarian, Fallopian Tube, and Primary Peritoneal Cancers Prevention</SummaryRef>.</Para></SummarySection></SummarySection><SummarySection id="_12"><Title>Ovarian, Fallopian Tube, and Primary Peritoneal Cancers Screening</Title><SummarySection id="_13"><SectMetaData><SectionType>Screening methods</SectionType></SectMetaData><KeyPoint id="_14">Tests are used to screen for different types of cancer when a person does  not have symptoms.</KeyPoint><Para id="_59"><GlossaryTermRef href="CDR0000044724" dictionary="Cancer.gov" audience="Patient">Scientists</GlossaryTermRef> study <GlossaryTermRef href="CDR0000046171" dictionary="Cancer.gov" audience="Patient">screening</GlossaryTermRef> tests to find those with the fewest harms and most benefits. <GlossaryTermRef href="CDR0000045333" dictionary="Cancer.gov" audience="Patient">Cancer</GlossaryTermRef> screening trials also are meant to show whether early detection (finding cancer before it causes <GlossaryTermRef href="CDR0000045022" dictionary="Cancer.gov" audience="Patient">symptoms</GlossaryTermRef>)  helps a person live longer or decreases a person's chance of dying from the disease. For some types of cancer, the chance of <GlossaryTermRef href="CDR0000454708" dictionary="Cancer.gov" audience="Patient">recovery</GlossaryTermRef> is better if the disease is found and treated at an early <GlossaryTermRef href="CDR0000045885" dictionary="Cancer.gov" audience="Patient">stage</GlossaryTermRef>.</Para></SummarySection><SummarySection id="_92"><KeyPoint id="_88">Screening for ovarian cancer may not help a person live longer.</KeyPoint></SummarySection><SummarySection id="_18"><KeyPoint id="_93">Screening tests that have been studied include:</KeyPoint><SummarySection id="_23"><KeyPoint id="_24">Pelvic exam</KeyPoint><Para id="_49"><GlossaryTermRef href="CDR0000322873" dictionary="Cancer.gov" audience="Patient">Pelvic exams</GlossaryTermRef> to screen for ovarian cancer have not been shown to decrease the number of deaths from the disease. A pelvic exam is an exam of the <GlossaryTermRef href="CDR0000046646" dictionary="Cancer.gov" audience="Patient">vagina</GlossaryTermRef>, <GlossaryTermRef href="CDR0000046133" dictionary="Cancer.gov" audience="Patient">cervix</GlossaryTermRef>, <GlossaryTermRef href="CDR0000046645" dictionary="Cancer.gov" audience="Patient">uterus</GlossaryTermRef>, <GlossaryTermRef href="CDR0000045687" dictionary="Cancer.gov" audience="Patient">fallopian tubes</GlossaryTermRef>, <GlossaryTermRef href="CDR0000046687" dictionary="Cancer.gov" audience="Patient">ovaries</GlossaryTermRef>, and <GlossaryTermRef href="CDR0000046555" dictionary="Cancer.gov" audience="Patient">rectum</GlossaryTermRef>.    A <GlossaryTermRef href="CDR0000046588" dictionary="Cancer.gov" audience="Patient">speculum</GlossaryTermRef> is inserted into the vagina, and the doctor or nurse looks at the vagina and cervix for signs of disease.  The doctor or nurse also inserts one or two <GlossaryTermRef href="CDR0000046302" dictionary="Cancer.gov" audience="Patient">lubricated</GlossaryTermRef>, gloved fingers of one hand into the vagina and places the other hand over the lower <GlossaryTermRef href="CDR0000045070" dictionary="Cancer.gov" audience="Patient">abdomen</GlossaryTermRef> to feel the size, shape, and position of the uterus and ovaries. The doctor or nurse also inserts a lubricated, gloved finger into the rectum to feel for lumps or <GlossaryTermRef href="CDR0000044636" dictionary="Cancer.gov" audience="Patient">abnormal</GlossaryTermRef> areas.<MediaLink ref="CDR0000609924" type="image/jpeg" alt="Pelvic exam; drawing shows a side view of the female reproductive anatomy during a pelvic exam. The uterus, left fallopian tube, left ovary, cervix, vagina, bladder, and rectum are shown. Two gloved fingers of one hand of the doctor or nurse are shown inserted into the vagina, while the other hand is shown pressing on the lower abdomen. The inset shows a woman covered by a drape on an exam table with her legs apart and her feet in stirrups." language="en" placement="image-center" id="_80"><Caption language="en">Pelvic exam. A doctor or nurse inserts one or two lubricated, gloved fingers of one hand into the vagina and presses on the lower abdomen with the other hand. This is done to feel the size, shape, and position of the uterus and ovaries. The vagina, cervix,  fallopian tubes, and rectum are also checked.</Caption></MediaLink></Para></SummarySection><SummarySection id="_26"><KeyPoint id="_27">Transvaginal ultrasound</KeyPoint><Para id="_50"><GlossaryTermRef href="CDR0000046633" dictionary="Cancer.gov" audience="Patient">Transvaginal ultrasound</GlossaryTermRef> (TVU) to screen for ovarian cancer has not been shown to decrease the number of deaths from the disease. TVU is a procedure used to examine the vagina, uterus, fallopian tubes, ovaries, and <GlossaryTermRef href="CDR0000046501" dictionary="Cancer.gov" audience="Patient">bladder</GlossaryTermRef>. An <GlossaryTermRef href="CDR0000367430" dictionary="Cancer.gov" audience="Patient">ultrasound transducer</GlossaryTermRef> (probe)  is inserted into the vagina and used to bounce high-energy sound waves off internal tissues or organs in the pelvis. These sound waves make echoes that form a picture of body tissues called a <GlossaryTermRef href="CDR0000046587" dictionary="Cancer.gov" audience="Patient">sonogram</GlossaryTermRef>.<MediaLink ref="CDR0000618018" type="image/jpeg" alt="Transvaginal ultrasound; drawing shows a side view of the female reproductive anatomy during a transvaginal ultrasound procedure. An ultrasound probe (a device that makes sound waves that bounce off tissues inside the body) is shown inserted into the vagina. The bladder, uterus, right fallopian tube, and right ovary are also shown. The inset shows the diagnostic sonographer (a person trained to perform ultrasound procedures) examining a woman on a table, and a computer screen shows an image of the patient’s internal tissues." language="en" placement="image-center" id="_81"><Caption language="en">Transvaginal ultrasound. An ultrasound probe connected to a computer is inserted into the vagina and is gently moved to show different organs. The probe bounces sound waves off internal organs and tissues to make echoes that form a sonogram (computer picture).</Caption></MediaLink></Para></SummarySection><SummarySection id="_29"><KeyPoint id="_30">CA-125 blood test</KeyPoint><Para id="_73">A <GlossaryTermRef href="CDR0000046490" dictionary="Cancer.gov" audience="Patient">CA-125</GlossaryTermRef> <GlossaryTermRef href="CDR0000688783" dictionary="Cancer.gov" audience="Patient">blood test</GlossaryTermRef> measures the level of CA-125, a substance released by cells into the bloodstream. An increased CA-125 level may be a sign of certain types of cancer, including ovarian cancer, or other conditions.</Para></SummarySection><Para id="_89">Studies have also shown that using CA-125 levels and TVU together to screen for ovarian cancer does not decrease the number of deaths from ovarian cancer.</Para></SummarySection><SummarySection id="_94"><KeyPoint id="_95">Screening tests for ovarian, fallopian tube, and primary peritoneal cancers are being studied in clinical trials.</KeyPoint><Para id="_94_md_95">Information about <GlossaryTermRef href="CDR0000045961" dictionary="Cancer.gov" audience="Patient">clinical trials</GlossaryTermRef> supported by <GlossaryTermRef href="CDR0000044267" dictionary="Cancer.gov" audience="Patient">NCI</GlossaryTermRef> can be found on NCI’s <ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials-search">clinical trials search</ExternalRef> webpage. Clinical trials supported by other organizations can be found on the <ExternalRef xref="https://clinicaltrials.gov/">ClinicalTrials.gov</ExternalRef> website.</Para></SummarySection></SummarySection><SummarySection id="_35"><SectMetaData><SectionType>Risks of screening</SectionType></SectMetaData><Title>Risks of Ovarian, Fallopian Tube, and Primary Peritoneal Cancers Screening</Title><SummarySection id="_36"><KeyPoint id="_37">Screening tests have risks.</KeyPoint><Para id="_38">Decisions about <GlossaryTermRef href="CDR0000046171" dictionary="Cancer.gov" audience="Patient">screening</GlossaryTermRef> tests can be difficult. Not all screening tests are helpful, and most have risks. Before having any screening test, you may
		  want to talk about  the test with your doctor.  It is important to know the risks of
		  the test and whether it has been proven to reduce the risk of dying from
		  cancer.</Para></SummarySection><SummarySection id="_39"><KeyPoint id="_40">The risks of ovarian, fallopian tube, and primary peritoneal cancers        screening tests include:</KeyPoint><SummarySection id="_65"><KeyPoint id="_66">Finding ovarian, fallopian tube, and primary peritoneal cancers may not improve health or help a  woman live
			 longer.</KeyPoint><Para id="_67">Screening
			 may not improve your health or help  you live longer if  you have   <GlossaryTermRef href="CDR0000478743" dictionary="Cancer.gov" audience="Patient">advanced</GlossaryTermRef> <GlossaryTermRef href="CDR0000445074" dictionary="Cancer.gov" audience="Patient">ovarian cancer</GlossaryTermRef> or if it has already spread to
			 other places in  your body.</Para></SummarySection><SummarySection id="_44"><KeyPoint id="_45">False-negative test results can occur.</KeyPoint><Para id="_46">Screening test results may appear to be normal even though ovarian cancer is
			 present. A woman who receives a <GlossaryTermRef href="CDR0000340928" dictionary="Cancer.gov" audience="Patient">false-negative test result</GlossaryTermRef> (one that
			 shows there is no cancer when there really is) may delay seeking medical care  even if there are symptoms.</Para></SummarySection><SummarySection id="_41"><KeyPoint id="_42">False-positive test results can occur.</KeyPoint><Para id="_61"> Screening test results may appear to be <GlossaryTermRef href="CDR0000044636" dictionary="Cancer.gov" audience="Patient">abnormal</GlossaryTermRef> even though no
			 cancer is present. A <GlossaryTermRef href="CDR0000340929" dictionary="Cancer.gov" audience="Patient">false-positive test result</GlossaryTermRef> (one that shows there is cancer when there really isn't) can cause <GlossaryTermRef href="CDR0000430405" dictionary="Cancer.gov" audience="Patient">anxiety</GlossaryTermRef> and is usually followed by more  tests and procedures  (such as
			  a <GlossaryTermRef href="CDR0000045556" dictionary="Cancer.gov" audience="Patient">laparoscopy</GlossaryTermRef> or a <GlossaryTermRef href="CDR0000045747" dictionary="Cancer.gov" audience="Patient">laparotomy</GlossaryTermRef> to see if cancer is present), which also have risks. Problems caused by tests used to <GlossaryTermRef href="CDR0000046450" dictionary="Cancer.gov" audience="Patient">diagnose</GlossaryTermRef> ovarian cancer include <GlossaryTermRef href="CDR0000045364" dictionary="Cancer.gov" audience="Patient">infection</GlossaryTermRef>, blood loss, <GlossaryTermRef href="CDR0000046500" dictionary="Cancer.gov" audience="Patient">bowel</GlossaryTermRef> injury, and heart and <GlossaryTermRef href="CDR0000045020" dictionary="Cancer.gov" audience="Patient">blood vessel</GlossaryTermRef> problems. A false-positive test result can also lead to an unneeded oophorectomy (removal of one or both <GlossaryTermRef href="CDR0000046687" dictionary="Cancer.gov" audience="Patient">ovaries</GlossaryTermRef>).</Para></SummarySection></SummarySection></SummarySection><SummarySection id="_AboutThis_1"><Title>About This PDQ Summary</Title><SummarySection id="_AboutThis_2"><Title>About PDQ</Title><Para id="_AboutThis_3">Physician Data Query (PDQ) is the National Cancer Institute's (NCI's) comprehensive cancer information database. The PDQ database contains summaries of the latest published information on cancer prevention, detection, genetics, treatment, supportive care, and complementary and alternative medicine. Most summaries come in two versions. The health professional versions have detailed information written in technical language. The patient versions are written in easy-to-understand, nontechnical language. Both versions have cancer information that is accurate and up to date and most versions are also available in <ExternalRef xref="https://www.cancer.gov/espanol/publicaciones/pdq">Spanish</ExternalRef>.</Para><Para id="_AboutThis_4">PDQ is a service of the NCI. The NCI is part of the National Institutes of Health (NIH). NIH is the federal government’s center of biomedical research.  The PDQ summaries are based on an independent review of the medical literature. They are not policy statements of the NCI or the NIH.</Para></SummarySection><SummarySection id="_AboutThis_5"><Title>Purpose of This Summary</Title><Para id="_AboutThis_6">This PDQ cancer information summary has current information about ovarian, fallopian tube, and primary peritoneal cancers screening.  It is meant to inform and help patients, families, and caregivers. It does not give formal guidelines or recommendations for making decisions about health care.</Para></SummarySection><SummarySection id="_AboutThis_7"><Title>Reviewers and Updates</Title><Para id="_AboutThis_8">Editorial Boards write the PDQ cancer information summaries and keep them up to date. These Boards are made up of experts in cancer treatment and other specialties related to cancer. The summaries are reviewed regularly and changes are made when there is new information. The date on each summary ("Updated") is the date of the most recent change.
</Para><Para id="_AboutThis_9">The information in this patient summary was taken from the health professional version, which is reviewed regularly and updated as needed, by the <ExternalRef xref="https://www.cancer.gov/publications/pdq/editorial-boards/screening-prevention">PDQ Screening and Prevention Editorial Board</ExternalRef>.
</Para></SummarySection><SummarySection id="_AboutThis_10"><Title>Clinical Trial Information</Title><Para id="_AboutThis_11">A clinical trial is a study to answer a scientific question, such as whether one treatment is better than another. Trials are based on past studies and what has been learned in the laboratory. Each trial answers certain scientific questions in order to find new and better ways to help cancer patients. During treatment clinical trials, information is collected about the effects of a new treatment and how well it works. If a clinical trial shows that a new treatment is better than one currently being used, the new treatment may become "standard." Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.
</Para><Para id="_AboutThis_12">Clinical trials can be found online at <ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials">NCI's website</ExternalRef>. For more information, call the <ExternalRef xref="https://www.cancer.gov/contact/contact-center">Cancer Information Service</ExternalRef> (CIS), NCI's contact center, at 1-800-4-CANCER (1-800-422-6237).
</Para></SummarySection><SummarySection id="_AboutThis_13"><Title>Permission to Use This Summary</Title><Para id="_AboutThis_14">PDQ is a registered trademark. The content of PDQ documents can be used freely as text. It cannot be identified as an NCI PDQ cancer information summary unless the whole summary is shown and it is updated regularly. However, a user would be allowed to write a sentence such as “NCI’s PDQ cancer information summary about breast cancer prevention states the risks in the following way: [include excerpt from the summary].”
</Para><Para id="_AboutThis_15">The best way to cite this PDQ summary is:</Para><Para id="_AboutThis_21">PDQ® Screening and Prevention Editorial Board. PDQ Ovarian, Fallopian Tube, and Primary Peritoneal Cancers Screening. Bethesda, MD: National Cancer Institute. Updated  &lt;MM/DD/YYYY&gt;. Available at: <ExternalRef xref="https://www.cancer.gov/types/ovarian/patient/ovarian-screening-pdq">https://www.cancer.gov/types/ovarian/patient/ovarian-screening-pdq</ExternalRef>.  Accessed &lt;MM/DD/YYYY&gt;. [PMID: 26389490]</Para><Para id="_AboutThis_16">Images in this summary are used with permission of the author(s), artist, and/or publisher for use in the PDQ summaries only. If you want to use an image from a PDQ summary and you are not using the whole summary, you must get permission from the owner. It cannot be given by the National Cancer Institute. Information about using the images in this summary, along with many other images related to cancer can be found in <ExternalRef xref="https://visualsonline.cancer.gov/">Visuals Online</ExternalRef>. Visuals Online is a collection of more than 3,000 scientific images.
</Para></SummarySection><SummarySection id="_AboutThis_17"><Title>Disclaimer</Title><Para id="_AboutThis_18">The information in these summaries should not be used to make decisions about insurance reimbursement. More information on insurance coverage is available on Cancer.gov on the <ExternalRef xref="https://www.cancer.gov/about-cancer/managing-care">Managing Cancer Care</ExternalRef> page.</Para></SummarySection><SummarySection id="_AboutThis_19"><Title>Contact Us</Title><Para id="_AboutThis_20">More information about contacting us or receiving help with the Cancer.gov website can be found on our <ExternalRef xref="https://www.cancer.gov/contact">Contact Us for Help</ExternalRef> page. Questions can also be submitted to Cancer.gov through the website’s <ExternalRef xref="https://www.cancer.gov/contact/email-us">E-mail Us</ExternalRef>.</Para></SummarySection></SummarySection><PatientVersionOf ref="CDR0000062760"/><DateLastModified>2025-05-08</DateLastModified></Summary>
